Select Committee on China and Congressional-Executive Commission on China Back DHS's Enforcement of UFLPA
September 3, 2026

Chairman John Moolenaar (R-MI) of the House Select Committee on China (SCC) and Chairman Chris Smith (R-NJ) of the Congressional Executive Commission on China (CECC) have sent a letter to Department of Homeland Security (DHS) Secretary Markwayne Mullin requesting a briefing on DHS’s implementation of the Uyghur Forced Labor Prevention Act (UFLPA).

Moolenaar to FDA: "Chinese Clinical Data Poses Real Risks for Patients"
August 21, 2026
Chairman John Moolenaar of the Select Committee on China (R-MI) and Congressman Ben Cline (R-VA) have sent a letter to Acting Commissioner Kyle Diamantas of the Food and Drug Administration (FDA) calling on the agency to stop the use of drug trial data from China for new clinical trial or drug applications unless the FDA has inspected the trial site in the past 12 months. The letter follows the tragic news of three deaths – including two children – that were covered up in drug trials in China.
Moolenaar: AI Chipmaker End-User Restrictions Undermined by Loopholes
August 10, 2026
Chairman John Moolenaar of the Select Committee on China recently sent a letter to Under Secretary Jeffrey Kessler at the Bureau of Industry and Security (BIS) asking the bureau to make it clear that the Foundry Due Diligence Rule remains in effect.
Moolenaar, Whitesides to Secretary Lutnick: Hold Firm on Chinese Memory Chips Ban
July 16, 2026

Chairman John Moolenaar (R-MI) of the House Select Committee on China and Congressman George Whitesides (D-CA), have sent a

Moolenaar, Smith: DOJ Must Launch Probe Into Vandalism of California Museum
July 9, 2026

Chairman John Moolenaar (R-MI) of the House Select Committee on China (SCC) and Congressman Chris Smith (R-NJ), Co-Chair of the Congressional-Executive Commission on China (CECC), sent a letter to Acting Attorney General Todd Blanche.

Select Committee: Owner of Capitals, Wizards Should Cut Ties with Chinese Military Company Alibaba
July 8, 2026

Chairman John Moolenaar of the Select Committee on China sent a letter to Ted Leonsis, the Chairman and CEO of Monumental Sports & Entertainment (MSE) and the owner of the Washington Capitals and Washington Wizards, requesting information regarding the nature of the partnership between MSE and Alibaba. The letter comes after last month’s decision by the Pentagon adding Alibaba to its updated list of companies linked to the Chinese military operating in the U.S.

Select Committee Investigates Bristol Myers Squibb For Clinical Trials at Chinese Military Sites
June 30, 2026

Chairman John Moolenaar of the Select Committee on China has sent a letter to Bristol Myers Squibb Chief Executive Officer Chris Boerner asking the pharmaceutical company to provide more information about the company's clinical drug trials in China.

GLP-1 Maker Lilly Funded Clinical Trials at Chinese Military Sites
June 30, 2026

Chairman John Moolenaar of the Select Committee on China (SCC) has sent a letter to Eli Lilly and Company Chief Executive Officer David Ricks asking the pharmaceutical company to provide more information about the company's clinical drug trials in China.

Keytruda Maker Merck Funded Clinical Trials at China’s Military Sites
June 30, 2026

Chairman John Moolenaar of the Select Committee on China has sent a letter to Merck Chief Executive Officer Robert Davis asking the pharmaceutical company to provide more information about the company's clinical drug trials in China.

Botox Maker AbbVie Funded Clinical Trials at Chinese Military Sites
June 30, 2026

Chairman John Moolenaar of the Select Committee on China (SCC) has sent a letter to AbbVie Chief Executive Officer Robert Michael asking the pharmaceutical company to provide more information about the company's clinical drug trials in China.